Navigation Links
Cordis Unveils Next Generation CoCr Coronary Stent
Date:3/11/2010

WATERLOO, Belgium, March 11, 2010 /PRNewswire/ --

- PRESILLION(TM) PLUS CoCr Coronary Stent Offers New Levels of Delivery, Support and Restoration for Arteriosclerotic Arteries

Cordis Corporation today announced the European launch of its next generation of bare metal stent system - PRESILLION(TM) PLUS. The new stent system, which improves upon the ground-breaking PRESILLION(TM), features important technological advances designed to gain easier access to distal lesions and help restore the artery's natural form.

"The new upgraded delivery system increases the speed of procedures with atraumatic delivery, increased pushability, and smoother withdrawal. We are very satisfied with the speed in which we were able to incorporate feedback from cardiologists into the new design," said Campbell Rogers MD, Global Head of R&D of Cordis Corporation.

The PRESILLION(TM) PLUS changes include a new hypotube for improved pushability in crossing calcified lesions and a redesigned semi-compliant balloon for precise stent deployment and decreased deflation time.

The PRESILLION(TM) PLUS stent is available in lengths from 8 to 33mm including a new 28mm addition and in diameters from 2.5 to 4.0mm.

The PIONIR study, designed to measure the safety and effectiveness of PRESILLION(TM) and PRESILLION(TM) PLUS, completed enrollment at 16 sites in Europe and Israel. The study, conducted by Medinol, includes 278 patients and will evaluate clinical performance through one year.

"Our vision at Cordis is to transform cardiovascular care, a field in which incredible progress has been made over the last decade, but one in which much more remains to be done. The new PRESILLION(TM) PLUS further complements our portfolio with its technological advances. We will continue to deliver innovative new solutions that save lives and improve the quality of life for people around the world," said Staffan Ternstrom, President, Cordis Europe, Middle-East, Africa.

Cordis Corporation is the exclusive global distributor of PRESILLION(TM) PLUS, which is designed and manufactured by Medinol Ltd, Israel. PRESILLION (TM) PLUS is a trademark of Cordis Corporation.

About Cordis Corporation

Cordis Corporation, a Johnson & Johnson company, is a worldwide leader in the development and manufacture of interventional vascular technology. Through the company's innovation, research and development, Cordis partners with interventional cardiologists worldwide to treat millions of patients who suffer from vascular disease. More information about Cordis Corporation can be found at http://www.cordis.com.

Cordis Corporation signed an exclusive distribution agreement with Medinol in 2008 and will be distributing PRESILLION (TM) PLUS globally. Medinol is a stent innovation company that develops both stents and delivery systems through design innovation and advanced manufacturing technologies.

    Media Contacts: Isabella Sharp
    APCO Worldwide
    isharp@apcoworldwide.com
    +44(0)20-7526-3632
    +44(0)7813-307490


SOURCE Cordis Corporation

Back to top
'/>"/>
SOURCE Cordis Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. DUSA Unveils Ergonomic Enhancements to BLU-U(R) at the American Academy of Dermatology Annual Meeting
2. FamilyCord Unveils Safer and More Effective Cord Blood Collection Kit
3. Quest Diagnostics Unveils Care360(TM) EHR
4. FDA Unveils Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging
5. Slovenias Sole Radiotherapy Hospital Unveils Novalis Tx(TM) Platform From Varian and BrainLAB
6. Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use
7. National Expressions of Courage Art Contest Unveils Stories of Inspiration
8. Aflex Unveils Revolutionary New Hose Design for the Chemical and Process Industry
9. Siemens Unveils New Hearing Loss Options at SPLASH: ADAs 2009 Convention
10. Ethicon Endo-Surgery Unveils Full Energy Portfolio for First Time at American College of Surgeons Clinical Congress
11. Eurotech Unveils New Diabetes Care Management Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Manufacturing Services Market Analysis By Service (Manufacturing, Research), By Country, ... - 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing ... 2025 Low drug registration cost in Latin American ...
(Date:4/19/2017)... 19, 2017 The Mobile X-Ray product segment is ... CAGR during the forecast period Mobile X-Ray segment ... digital mobile X-Ray devices market, which is estimated to be ... at a CAGR of 7% over the forecast period. Mobile ... more than US$ 100 Mn in 2017 over 2016. The ...
(Date:4/19/2017)... YORK , April 19, 2017 ... This report on the prostate cancer therapeutics ... the global market. Increasing prevalence of prostate cancer, ... innovation in the development of new drugs & ... prostate cancer drug due to lesser side effects ...
Breaking Medicine Technology:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... been previously exposed to more adverse experiences than children in the general population. ... such as abuse, neglect or other family challenges. While no fault of their ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and elimination ... safety and minimize the cost of development. In this webinar, sponsored by Molecular ... lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , In ...
(Date:4/28/2017)... ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in ... responds to and which He does not. Yisrayl says with so many titles and ... true name, but he says with a little Scripture, backed with a lot of research, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Intellitec Solutions announced the ... implement a Microsoft Dynamics GP solution that integrates to their PointClickCare EHR software ... in long-term care, Brooke Grove now has the capability to achieve its goal ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Rob Lowe is ... now he has leant his presence to an educational purpose as the host of ... important one being cancer. In a recent episode, the series focuses on thyroid cancer. ...
Breaking Medicine News(10 mins):